Replies to post #61 on Proteon Therapeutics, Inc. (PRTO)

[Whalatane]

Jt .....so this final trial is only Rc AVF and at 30 ug dose ?

I guess I'm cautious because
1) I lost $ in the original trial ...:-)
2) P values looked marginal in previous trial and you need both the now agreed upon endpts to be stat sig
in the remaining trial.

Well I was to cautious on R-IT results also ..so what do I know. !

Whats your argument for why both endpts in the final Patency trial will be stat sig ?
thx
Kiwi

[Whalatane]

Jt

Wife likes the following data ( from J of vascular surgery )


For patients who were prehemodialysis patients at randomization, the incidences of unassisted or assisted use were 63% (44/70) for vonapanitase and 37% (13/35) for placebo (P 1/4 .013).
In the subset of these patients who had their fistula created at least 6 weeks before the initiation of hemodialysis, 65% (32/49) of vonapanitase and 37% (7/19) of placebo patients initiated hemodialysis through the study fistula (P 1/4 .033). [/I]


Kiwi